News - Patient Care Device

World Malaria Day: Five latest devices to combat the spread of malaria

For World Malaria Day, we profile five medical devices preventing the spread of malaria across the developing regions of the world

Government of Zimbabwe and GlobalMed partner to pilot virtual care project

GlobalMed was selected by the Government of Zimbabwe for a United Nations-funded project to provide telemedicine services and equipment at 16 clinics in the country's Manicaland province.

FDA approves Current Health’s patient monitoring solution for in-home care

Scotland-based Current Health has secured class II clearance from the US Food and Drug Administration (FDA) for its remote patient monitoring solution for post-acute care applications.

Dreem 2: The new device that uses data to battle insomnia

Today marks the launch of the new Dreem 2, a new, improved, lightweight headband that uses data to help insomniacs understand and treat their lack of sleep.

GreatCall launches new medical alert device for safety of older adults

GreatCall, a provider of active aging and independent living solutions, has introduced a new medical alert device, Lively Mobile Plus, which keeps older adults safe and independent.

AEGEA Medical completes enrollment in PACE MX

AEGEA Medical announced that it has completed enrollment in the Post-Ablation Cavity Evaluation Mexico (PACE MX) clinical study of women who previously underwent endometrial ablation as part of a pivotal trial of AEGEA’s Mara Water Vapor Ablation Treatment.

Imbed Biosciences closes $2m in series A financing

Imbed Biosciences, a medical device company developing advanced therapies for soft tissue repair, has closed $2 million in a Series A Preferred Stock equity financing.

RMS Medical Products receives FDA 510(k) clearance for subcutaneous needle sets

Repro Med Systems, dba RMS Medical Products has received 510(k) clearance from the US Food and Drug Administration (FDA) for its HIgh-Flo Super26 subcutaneous needle sets (Super 26 Needle Sets).

NeuroSigma gets FDA approval for Monarch eTNS system to treat ADHD

NeuroSigma has secured approval from the US Food and Drug Administration (FDA) to market its medical device for the treatment of attention deficit hyperactivity disorder (ADHD).